HUT47033A - Process for production of medical compositions against tumor - Google Patents
Process for production of medical compositions against tumorInfo
- Publication number
- HUT47033A HUT47033A HU883081A HU308188A HUT47033A HU T47033 A HUT47033 A HU T47033A HU 883081 A HU883081 A HU 883081A HU 308188 A HU308188 A HU 308188A HU T47033 A HUT47033 A HU T47033A
- Authority
- HU
- Hungary
- Prior art keywords
- production
- against tumor
- compositions against
- medical compositions
- medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP87108708A EP0295317A1 (en) | 1987-06-16 | 1987-06-16 | Pharmaceutical composition for the treatment of tumors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT47033A true HUT47033A (en) | 1989-01-30 |
HU200942B HU200942B (en) | 1990-09-28 |
Family
ID=8197069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU883081A HU200942B (en) | 1987-06-16 | 1988-06-15 | Process for producing pharmaceutical compositions suitable for treating tumours, comprising dipyridamol or dipyridamol and interferon |
Country Status (11)
Country | Link |
---|---|
US (1) | US4997645A (hu) |
EP (2) | EP0295317A1 (hu) |
JP (1) | JPS63316722A (hu) |
KR (1) | KR890000108A (hu) |
AT (1) | ATE59780T1 (hu) |
AU (1) | AU622404B2 (hu) |
DE (1) | DE3861494D1 (hu) |
DK (1) | DK328088A (hu) |
HU (1) | HU200942B (hu) |
PH (1) | PH27069A (hu) |
ZA (1) | ZA884262B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5215744A (en) * | 1987-06-16 | 1993-06-01 | Boehringer Ingelheim Gmbh | Methods for the treatment of tumors |
GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
US6003516A (en) * | 1992-06-03 | 1999-12-21 | Maxim Pharmaceuticals, Inc. | Method for treatment of cancer and infectious disease |
SE513429C2 (sv) * | 1992-06-03 | 2000-09-11 | Syntello Inc | Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer |
US5480640A (en) * | 1995-05-02 | 1996-01-02 | Schering Corporation | Alpha interferon for treating prostate cancer |
US6155266A (en) | 1995-05-08 | 2000-12-05 | Maxim Pharmaceuticals, Inc. | Method for treatment of cancer and infectious disease |
US20020099003A1 (en) | 1997-10-28 | 2002-07-25 | Wilson Leland F. | Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof |
US7064130B2 (en) * | 2001-04-20 | 2006-06-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders |
WO2020065036A1 (en) * | 2018-09-27 | 2020-04-02 | Iteos Therapeutics S.A. | Use of an inhibitor of an ent family transporter in the treatment of cancer and combination thereof with an adenosine receptor antagonist |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3031450A (en) * | 1959-04-30 | 1962-04-24 | Thomae Gmbh Dr K | Substituted pyrimido-[5, 4-d]-pyrimidines |
BG36086A1 (en) * | 1982-01-19 | 1984-09-14 | Glbov | Method for inducing interferon |
-
1987
- 1987-06-16 EP EP87108708A patent/EP0295317A1/en not_active Withdrawn
-
1988
- 1988-04-06 JP JP63084985A patent/JPS63316722A/ja active Granted
- 1988-06-08 DE DE8888109121T patent/DE3861494D1/de not_active Expired - Fee Related
- 1988-06-08 AT AT88109121T patent/ATE59780T1/de active
- 1988-06-08 EP EP88109121A patent/EP0295559B1/en not_active Expired - Lifetime
- 1988-06-14 KR KR1019880007101A patent/KR890000108A/ko not_active Application Discontinuation
- 1988-06-15 HU HU883081A patent/HU200942B/hu not_active IP Right Cessation
- 1988-06-15 DK DK328088A patent/DK328088A/da unknown
- 1988-06-15 ZA ZA884262A patent/ZA884262B/xx unknown
- 1988-06-15 AU AU17681/88A patent/AU622404B2/en not_active Ceased
- 1988-06-16 US US07/207,622 patent/US4997645A/en not_active Expired - Fee Related
- 1988-06-16 PH PH37080A patent/PH27069A/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU200942B (en) | 1990-09-28 |
DK328088A (da) | 1988-12-17 |
EP0295559B1 (en) | 1991-01-09 |
US4997645A (en) | 1991-03-05 |
DK328088D0 (da) | 1988-06-15 |
JPS63316722A (ja) | 1988-12-26 |
JPH0529365B2 (hu) | 1993-04-30 |
EP0295317A1 (en) | 1988-12-21 |
ATE59780T1 (de) | 1991-01-15 |
KR890000108A (ko) | 1989-03-11 |
PH27069A (en) | 1993-02-01 |
AU1768188A (en) | 1988-12-22 |
DE3861494D1 (de) | 1991-02-14 |
ZA884262B (en) | 1990-02-28 |
EP0295559A3 (en) | 1989-03-08 |
EP0295559A2 (en) | 1988-12-21 |
AU622404B2 (en) | 1992-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT47022A (en) | Process for production of medical compositions | |
GB2092159B (en) | Process for the production of human colony stimulating factor | |
HUT42953A (en) | Process for production of medical compositions | |
AU583992B2 (en) | Process for heat treatment of coal | |
HUT47259A (en) | Process for production of tetrasole-derivatives decreasing the patalogically high colestherin-level of blood | |
HUT40564A (en) | Process for production of medical preparatives applicable for treatment of pathalogical histogenesis | |
HUT47033A (en) | Process for production of medical compositions against tumor | |
HUT42950A (en) | Process for production of medical compositions with delayed effect | |
GR3024763T3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
HU200093B (en) | Process for production of medical compositions against tumour | |
EP0378824A3 (en) | Use of omega-3-fatty acids as anticachexia agents | |
DE3572441D1 (en) | Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases | |
GB8417350D0 (en) | Producing human interferon productivity of blood | |
GB2242367B (en) | Apparatus for the production of oxygenated blood | |
HUT46044A (en) | Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same | |
EP0200212A3 (en) | Process for producing polythiobisphenols and process for producing mercaptophenols by the hydrogenolysis of the same | |
HUT40576A (en) | Process for producing human leucocite interferon | |
GB2122897B (en) | Treatment of cancer with microorganisms obtained products | |
DE3362010D1 (en) | Process for the batch-wise production of vinegar | |
GR3018837T3 (en) | Subcutaneous administration of human chorionic gonadotrophin. | |
IL63456A0 (en) | Alpha-substituted ureidobenzylpenicillanic acid and process for producing the same | |
IL90021A0 (en) | Process for the production of interferon | |
HUT40138A (en) | Process for producing novel 13 alpha- alkyl-17 beta-/3-acyloxyl-propyl/gonanes | |
JO1400B1 (en) | Method for preparing pharmacy formulations | |
HUT42949A (en) | Process for production of medical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |